Literature DB >> 14745727

Osteofibrous dysplasia and adamantinoma: correlation of proto-oncogene product and matrix protein expression.

Masahiiko Maki1, Nicholas Athanasou.   

Abstract

To investigate the relationship between osteofibrous dysplasia (OFD) and adamantinoma, we analyzed the expression of several proto-oncogene products and extracellular matrix proteins by immunohistochemistry and correlated our results with histological and ultrastructural findings. C-fos and c-jun, but not c-Met, were observed in OFD and in the fibrous and epithelial components of differentiated and classical adamantinomas. Staining for collagen IV, laminin and galectin-3, a laminin binding protein was seen in OFD and around cell nests in adamantinoma. E-, P-, and N-cadherin expression was found in all cases of classical adamantinoma, but not in differentiated adamantinoma or OFD. Osteonectin was detected in both the epithelial and fibrous components of adamantinomas, but osteopontin and osteocalcin were not seen in classical adamantinomas. The results show common expression of a number of oncoproteins and bone matrix proteins in adamantinoma and OFD, some of which are associated with mesenchymal-to-epithelial cell transformation. These findings would be in keeping with the hypothesis that OFD represents a precursor lesion of adamantinoma. Differential expression of a number of bone matrix protein in adamantinoma may also be of diagnostic use in distinguishing these 2 lesions immunohistochemically.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14745727     DOI: 10.1016/j.humpath.2003.07.008

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  7 in total

1.  Podoplanin expression in adamantinoma of long bones and osteofibrous dysplasia.

Authors:  Takeshi G Kashima; Arunthati Dongre; Adrienne M Flanagan; Pancras C W Hogendoorn; Richard Taylor; Nicholas A Athanasou
Journal:  Virchows Arch       Date:  2011-04-16       Impact factor: 4.064

Review 2.  Benign fibro-osseous lesions of the craniofacial complex. A review.

Authors:  Roy Eversole; Lan Su; Samir ElMofty
Journal:  Head Neck Pathol       Date:  2008-05-13

3.  Adamantinoma of long bones: a long-term follow-up study of 11 cases.

Authors:  Miklós Szendroi; Imre Antal; Gabriella Arató
Journal:  Pathol Oncol Res       Date:  2008-12-02       Impact factor: 3.201

4.  Primary adamantinoma of the rib. Unusual presentation for a bone neoplasm of uncertain origin.

Authors:  Sergio Piña-Oviedo; Luis Del Valle; Rafael Padilla-Longoria; Hilda Mendoza-Ramón; Carlos Ortiz-Hidalgo
Journal:  Pathol Oncol Res       Date:  2008-04-12       Impact factor: 3.201

Review 5.  Adamantinoma: An Updated Review.

Authors:  Dimitrios N Varvarousis; Georgios P Skandalakis; Alexandra Barbouti; Georgios Papathanakos; Panagiotis Filis; Kostas Tepelenis; Aikaterini Kitsouli; Panagiotis Kanavaros; Panagiotis Kitsoulis
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

6.  Adamantinoma: a clinicopathological review and update.

Authors:  Deepali Jain; Vijay K Jain; Rakesh K Vasishta; Prabhat Ranjan; Yashwant Kumar
Journal:  Diagn Pathol       Date:  2008-02-15       Impact factor: 2.644

Review 7.  Adamantinoma of the distal femur diagnosed 5 years after initial surgery: a case report.

Authors:  Kai Cao; Michiro Susa; Itsuo Watanabe; Kazumasa Nishimoto; Keisuke Horiuchi; Aya Sasaki; Yuichiro Hayashi; Katsura Emoto; Kaori Kameyama; Masaya Nakamura; Morio Matsumoto; Hideo Morioka
Journal:  J Med Case Rep       Date:  2016-06-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.